Newsroom
Category
October 28, 2025
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Honor highlights excellence in cancer care, research and innovation SAN ANTONIO, Oct. 28, 2025 – UT Health San Antonio’s Mays Cancer Center has been named among the nation’s leading hospitals and health systems for excellence in oncology programs, according to Becker’s Hospital Review. The publication’s annual list features more than […]
October 10, 2025
UT Health San Antonio’s Mays Cancer Center is hosting a Grand Rounds Oct. 15 — Global Lobular Breast Cancer Awareness Day — to spotlight new approaches to diagnosis and treatment of invasive lobular carcinoma, a common but often overlooked form of breast cancer.
October 1, 2025
Elizabeth Wasmuth, PhD, assistant professor in the Department of Biochemistry and Structural Biology of the Joe R. and Teresa Lozano Long School of Medicine and co-director of the cryo-EM facility at The University of Texas at San Antonio, has been selected by the Howard Hughes Medical Institute (HHMI) as a Freeman Hrabowski Scholar. The five-year […]
September 16, 2025
Contact: Eileen Teves, 210-450-7239 Mays Cancer Center joins leading NCI-Designated Cancer Centers in a unified statement to raise awareness about vaccine SAN ANTONIO, Sept. 16, 2025 — Today, the Mays Cancer Center at The University of Texas San Antonio Health Science Center, along with 61 National Cancer Institute (NCI)-Designated Cancer Centers with leading national organizations […]
August 5, 2025
FOR IMMEDIATE RELEASE August 5, 2025 Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu MEDIA ADVISORY UT Health San Antonio gears up to drive out childhood cancer Receives grant from Hyundai Hope on Wheels® to continue its fight against the disease WHAT: In the United States, 43 children are diagnosed with cancer every day. To help in the […]
July 17, 2025
FOXM1 protein identified as key driver in immunotherapy resistance, unlocking new therapeutic avenues For years, scientists have found the overexpression of a specific protein called FOXM1 in a wide range of cancers, including ovarian, breast and pediatric cancers. A recent study by scientists at The University of Texas Health Science Center at San Antonio […]